APPLYING THE AUSTRALIAN GUIDELINES FOR THE REIMBURSEMENT OF PHARMACEUTICALS

被引:8
作者
ARISTIDES, M
MITCHELL, A
机构
[1] Pharmaceutical Benefits Branch, Departtment of Human Services and Health, Canberra, Australian Capital Territory, 2601
关键词
D O I
10.2165/00019053-199406030-00003
中图分类号
F [经济];
学科分类号
02 ;
摘要
[No abstract available]
引用
收藏
页码:196 / 201
页数:6
相关论文
共 7 条
[1]  
Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses, Department of Health. Housing and community Services, (1992)
[2]  
Draft guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits, Advisory Committee: including submission involving economic analyses, (1990)
[3]  
Henry D., Economic analysis as an aid to subsidisation: the development of Australian guidelines for pharmuceuticals, Pharmaco Economics, 1, pp. 54-67, (1992)
[4]  
Drummond M.F., Stoddart G.L., Torrance, Methods for the economic evaluation of health care programmes, (1987)
[5]  
Manual of resource items and their associated costs: for use in submissions to the Pharmaceutical Benefits Advisory CommiHtt involving eonomic analyses, Department of Health. Housing. Local Government and Community Services, (1993)
[6]  
Evans D., Freund D., Dittus R., Et al., Background document: on the use of eonomic analysis as a basis for inclusion of pharmaceutical products on the Pharmaceutical Benefits Scheme, Department of Health. Housing. Local Government and Community Services, (1990)
[7]  
Koopmanschap M.A., Rutten F.F.H., Indirect costs, in economic studies: confronting the confusion, Pharmaco Economics, 4, (1993)